Orion Infusions (DHA:ORIONINFU) Other Net Income (Loss) : BDT0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Other Net Income (Loss)?

Orion Infusions's Other Net Income (Loss) for the three months ended in Mar. 2024 was BDT-0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was BDT0.0 Mil.

Orion Infusions's quarterly Other Net Income (Loss) increased from Sep. 2023 (BDT0.0 Mil) to Dec. 2023 (BDT0.0 Mil) but then declined from Dec. 2023 (BDT0.0 Mil) to Mar. 2024 (BDT-0.0 Mil).

Orion Infusions's annual Other Net Income (Loss) declined from Jun. 2021 (BDT0.0 Mil) to Jun. 2022 (BDT-0.0 Mil) but then stayed the same from Jun. 2022 (BDT-0.0 Mil) to Jun. 2023 (BDT-0.0 Mil).

Orion Infusions Other Net Income (Loss) Historical Data

The historical data trend for Orion Infusions's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Other Net Income (Loss) Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Net Income (Loss)

Get a 7-Day Free Trial

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Orion Infusions Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.0 Mil.

Orion Infusions Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines